Literature DB >> 11122498

Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies.

S Hahn1, P R Williamson, J L Hutton, P Garner, E V Flynn.   

Abstract

Subgroup analysis is frequently used to investigate heterogeneity in meta-analysis. Subgroup data are not always available, and researchers should record what data were available for each trial. If data were not available, and it is known that the subgroup data were collected, the potential for selective reporting should be considered. Bias due to selective publishing of reports is widely recognized in meta-analysis. In contrast, selective reporting within studies is little discussed but potentially important. We explored this problem by evaluating the effect of potential bias in subgroup analysis due to within-study selective reporting with an existing meta-analysis. The review addressed malaria chemoprophylaxis in pregnancy. The conclusion in the original review, that benefit is limited to primigravidae, was based on subgroup analysis using the three trials out of five which reported on subgroups. We developed a method of sensitivity analysis that imputes data for the missing subgroups to assess the robustness of the results and the conclusions drawn. In this particular example, our analysis indicates that the estimate of effect reported in the review is most likely to overestimate the true effect and the conclusion that benefit is limited to primigravidae may be false. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 11122498     DOI: 10.1002/1097-0258(20001230)19:24<3325::aid-sim827>3.0.co;2-d

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  24 in total

1.  Selective outcome reporting: telling and detecting true lies. The state of the science.

Authors:  Ana Macura; Iosief Abraha; Jamie Kirkham; Gian Franco Gensini; Lorenzo Moja; Alfonso Iorio
Journal:  Intern Emerg Med       Date:  2010-03-19       Impact factor: 3.397

2.  Interaction trees with censored survival data.

Authors:  Xiaogang Su; Tianni Zhou; Xin Yan; Juanjuan Fan; Song Yang
Journal:  Int J Biostat       Date:  2008-01-28       Impact factor: 0.968

3.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

Review 4.  Effects of Oestrogen Treatment on Skeletal Response to Exercise in the Hips and Spine in Postmenopausal Women: A Meta-Analysis.

Authors:  Renqing Zhao; Zhengang Xu; Meihua Zhao
Journal:  Sports Med       Date:  2015-08       Impact factor: 11.136

5.  Smoking before the first pregnancy and the risk of breast cancer: a meta-analysis.

Authors:  Lisa A DeRoo; Peter Cummings; Beth A Mueller
Journal:  Am J Epidemiol       Date:  2011-06-30       Impact factor: 4.897

Review 6.  Efficiency of jumping exercise in improving bone mineral density among premenopausal women: a meta-analysis.

Authors:  Renqing Zhao; Meihua Zhao; Liuji Zhang
Journal:  Sports Med       Date:  2014-10       Impact factor: 11.136

Review 7.  Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa.

Authors:  Helen L Guyatt; Robert W Snow
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  BMJ       Date:  2009-07-21

9.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

10.  Mortality benefit of isoniazid preventive therapy in HIV-positive persons: a simulation study.

Authors:  M A Bachhuber; R Gross
Journal:  Int J Tuberc Lung Dis       Date:  2009-08       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.